Synjardy xr side effects, by duration, gender and age (a phase IV clinical study of FDA data)

Summary:

Side effects are reported by people who take Synjardy xr (empagliflozin; metformin hydrochloride). Common side effects include blood glucose increased among females and diabetic ketoacidosis among males.

The phase IV clinical study is created by eHealthMe based on 560 reports from the FDA, and is updated regularly.

What is Synjardy Xr?

Synjardy xr has active ingredients of empagliflozin; metformin hydrochloride. eHealthMe is studying from 564 Synjardy xr users. Check the latest studies of Synjardy xr.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 26, 2026

560 people who take Synjardy Xr and have side effects are studied.

Synjardy xr side effects.

What are the common side effects of Synjardy xr, by gender? *

Click here to view

What are the common side effects of Synjardy xr, by age (0-1 to 60+)? *

Click here to view

What are the common side effects of Synjardy xr, by the time people have been on the drug (< 1 month to 10+ years)? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Synjardy xr?

- Personalize this study to your gender and age
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.



How the study uses the data?

The study is based on empagliflozin; metformin hydrochloride (the active ingredients of Synjardy xr) and Synjardy xr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies are listed below in case you need more information:

Alternative drugs to, pros and cons of Synjardy xr:

All Synjardy xr side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: